Programmed death ligand (PD-L1) maintains CSC stemness by promoting OCT4 phosphorylation, but the histone demethylase jumonji domain-containing protein-3 (JMJD3) decreases breast cancer stem cell-like properties by downregulating OCT4 [80,81]. This evidence concerns the gene POU5F1 and breast carcinoma.